The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...

Chief Minister of Khyber Pakhtunkhwa, Ali Amin Khan Gandapur, has decided in principle to include the rehabilitation of drug addicts in the Sehat Card scheme and directed the relevant authorities to ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...